Abstract
In the United States, the currently estimated number of deaths owing to upper digestive (oral cavity, pharynx, and esophagus) and respiratory (larynx and lung) tract cancers represents almost 40% of the overall cancer mortality rate in males and 23% in females. Of the approximately 1,040,000 incidences of cancers in men and women estimated for 1990 in the United States, 20% have been diagnosed in the aerodigestive tract (Table 1) (1). Aerodigestive tract cancer incidence rates appear more commonly in males throughout the world, where the male:female incidence ratios may vary between 2 and 6, and, within most geographic areas, vary inversely with socioeconomic status. In North America and Western Europe, the major risk factors for aerodigestive tract squamous cell carcinomas (SCCs) are alcohol and tobacco. Approximately 140,000 deaths in the United States each year, owing to upper digestive and respiratory tract cancers, can be attributed to cigarette smoking and alcohol consumption.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Cancer Society. Cancer Facts and Figures, 1990.
Gloeckler-Ries LA, Hankey BF, Edwards BK. Cancer Statistics Review 1973–1987. U.S. Department of Health and Human Services, National Cancer Institute, NIH Publication No. 90–2789.
Moore C, Catlin D. Anatomic origins and locations of oral cancer. Am J Surg 114:510–513,1967.
Muir C, Waterhouse J, Mack T, Powell J, Whelan S. Cancer Incidence in Five Continents (Vol. V). Lyon, International Agency for Research on Cancer, Scientific Publication No. 88, 1987.
Schottenfeld D. Epidemiology of cancer of the esophagus. Semin Oncol 11:92–100,1984.
Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265:1287–1289, 1991.
Sartori S, Nielsen I, Indelli M, Trevisani L, Pazzi P, Grandi E. Barrett’s esophagus after chemotherapy with cyclophosphamide, methotrex ate, and 5-fluorouracil (CMF): An iatrogenic injury. Ann Intern Med 114:210–211, 1991.
Yang PC, Thomas DB, Daling JR, David S. Differences in the sex ratio of laryngeal cancer incidence rates by anatomic subsite. J Clin Epidemiol 42:755–758, 1989.
Devesa SS, Blot WJ, Fraumeni JF Jr. Cohort trends in mortality from oral, esophageal and laryngeal cancers in the United States. Epidemiology 1:116–121,1990.
McMichael AJ. Increases in laryngeal cancer in Britain and Australia in relation to alcohol and tobacco consumption trends. Lancet 1:1244–1247,1978.
Novotny TE, Warner KE, Kendrick JS, Remington PL. Smoking by blacks and whites: Socioeconomic and demographic differences. Am J Public Health 78:1187–1189,1988.
Walker WJ, Brin BN. United States lung cancer mortality and declining cigarette tobacco consumption. J Clin Epidemiol 41:179–185,1988.
Garfinkel L, Stcllman SD. Smoking anti lung cancer in women: Findings in a prospective study. Cancer Res 48:6951–6955, 1988.
Centers for Disease Control. Cigarette smoking-Behavioral risk factor surveillance system. MMWR 38:845–848,1989.
Escobedo LG, Anda RF, Smith PF, Remington PL, Mast EE. Sociodemographic characteristics of cigarette smoking initiation in the United States. Implications for smoking prevention policy. JAMA 264:1550–1555, 1990.
Yu MC, Henderson BF. Nasopharynx. In Scholia’ Feld D, Fraumeni JF Jr (eds): Cancer Epidemiology and Prevention. 2d ed. New York: Oxford University Press, in press.
Pagano JS. Epstein-Barr virus transcription in nasopharyngeal carcinoma. J Virol 48:580–589, 1983.
Henle W, Henle G. Epstein-Barr virus and human malignancies. Advances in Viral Oncology 5:201–238, 1985.
Ning J-P, Yu MC, Wang Q-S, Henderson BE. Consumption of salted fish and other risk factors fornasopharyngeal carcinoma (NPC) in Tianjin, a low-risk region for NPC in the People’s Republic of China. J Nail Cancer Inst 82:291–296, 1990.
Frank AL. Occupational cancers of the respiratory system. Seminars in Occupational Medicine 2:257–266,1987.
Vaughan TL, Davis S. Wood dust exposure and squamous cell cancers of the upper respiratory tract. Am J Epidemiol 133:500–564, 1991.
Roush GC. Nasal cavity and paranasal sinuses. In Schottenfeld D, Fraumeni JF Jr (eds): Cancer Epidemiology and Prevention. 2d ed. New York: Oxford University Press, in press.
Slaughter DP, Southwick HW, Smejkal W. “Field cancerization” in oral stratified squamous epithelium: Clinical implications of multicentric origin. Cancer 6:963–968, 1953.
Strong MS, Incze J, Vaughan CW. Field cancerization in the aerodigestive tract: Its etiology, manifestation and significance. J Otolaryngol 13:1–6,1984.
Winn DM, Blot WJ. Second cancers following cancers of the buccal cavity and pharynx in Connecticut, 1935–1982. In National Cancer Institute Monograph no. 68. Washington, D.C.: Government Printing Office, 1985, pp. 25–48 (NIH publication no. 85–2714).
Schottenfeld D, Gantt RC, Wynder EL. The role of alcohol and tobacco in multiple primary cancers of the upper digestive system, larynx and lung: A prospective study. Prey Med 3:277–293, 1974.
Jeffrey PK. Tobacco smoke-induced lung disease. In Cohen RD, Lewis B, Alberti KGMM, Denman AM (eds): The Metabolic and Molecular Basis of Acquired Disease. London: Bailliere, Tindall, 1990, pp. 466–495.
Hoffmann D, Hecht SS. Nicotine-derived N-nitrosamines and tobacco-related cancer: Current status and future directions. Cancer Res 45:935–944, 1985.
Hoffmann D, Adams JD, Lisk D, Fisenne I, Brunnemann KD. Toxic and carcinogenic agents in dry and moist snuff. J Natl Cancer Inst 79:1281–1286, 1987.
Hecht SS, Hoffmann D. The relevance of tobacco-specific nitrosamines to human cancer. Cancer Sury 8:273–294, 1989.
Kahn HA. The Dorn study on smoking and mortality among U.S. veterans: Report on 8–1/2 years of observation. In Haenszel W (ed): Epidemiological Approaches to the Study of Cancer and Other Chronic Diseases. National Cancer Institute Monograph no. 19. Bethesda, MD, 1966, pp. 1–125.
Stellman SD, Garfinkel L. Lung cancer risk is proportional to cigarette tar-yield: Evidence from a prospective study. Prey Med 18:518–525, 1989.
Stellman SD, Garfinkel L. Smoking habits and tar levels in a new American Cancer Society prospective study of 1.2 million men and women. J Natl Cancer Inst 76:1057–1063, 1986.
Wynder EL, Stellman SD. Comparative epidemiology of tobacco-related cancers. Cancer Res 37:4608–4622, 1977.
U.S. Department of Health and Human Services. The Health Benefits of Smoking Cessation: A Report of the Surgeon General, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, DH HS Publication No. (CDC) 90–8416, 1990.
Peto R. Influence of dose and duration of smoking on lung cancer rates. In Zaridze DG, Peto R (eds): Tobacco: A Major International Health Hazard. Lyon: International Agency for Research on Cancer, 1986, pp. 23–33.
Doll R, Peto R. Cigarette smoking and bronchial carcinoma: Dose and time relationships among regular smókers and life-long nonsmokers. J Epidemiol Community Health 32:303–313, 1978.
Doll R, Peto R. Mortality in relation to smoking: 20 Years’ observations on male British doctors. Br Med J 2:1525–1536, 1976.
Freedman DA, Navidi WC. Ex-smokers and multistage model for lung cancer. Epidemiology 1:21–29, 1990.
Winn DM, Blot WJ, Shy CM, Pickle LW, Toledo A, Fraumeni JF Jr. Snuffdippingandoralcanceramongwomen in the southern United States. N Engl J Med 304:745–749, 1981.
International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Tobacco Habits Other Than Smoking; Betel Quid and Areca Nut Chewing; and Some Related Nitrosamines, vol. 37. Lyon: World Health Organization, 1985.
Gupta PC, Pindborg JJ, Mehta FS. Comparison of carcinogenicity of betel quid with and without tobacco: An epidemiological review. Ecology and Disease I:213–219, 1982.
Lieber CS. Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. N Engl J Med 319:1639–1650, 1988.
International Agency for Research on Cancer. Alcohol Drinking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 44. Lyon: World Health Organization, 1988.
Obe G, Ristow H. Acetaldehyde but not alcohol induces sister chromatid exchanges in Chinese hamster cells in vitro. Mutat Res 56:211–213, 1977.
Kissin B. Epidemiologic investigation of possible biological interactions of alcohol and cancer of the head and neck. Ann N Y Acad Sci 252:374–384, 1975.
Schottenfeld D. Alcohol as a co-factor in the etiology of cancer. Cancer 43:1962–1966, 1979.
Rothman K, Keller AZ. The effect of joint exposure to alcohol and tobacco on risk of cancer of the mouth and pharynx. Journal of Chronic Disease 25:711–716, 1972.
Tuyns AI, Estere J, Raymond L, Bcrrino F, Benhamou E, Blanchet F, Boffetta P, Crosignani P, del Moral A, Lehmann W, Merletti F, Pequignot G, Riboli E, Sancho-Gamier H, Terracini B, Zubiri A, Zubiri Z. Cancer of the larynx/hypopharynx, tobacco and alcohol. Im J Cancer 41:483–491, 1988.
Flanders WD, Rothman KJ. Interaction of alcohol and tobacco in laryngeal cancer. Am J Epidemiol 115:371–379, 1982.
Notani PN. Role of alcohol in cancers of the upper alimentary tract: Use of models in risk assessment. J Epidemiol Community Health 42:187–192, 1988.
Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Bernstein L, Schoenberg JB, Stemhagen A, Fraumeni JF Jr. Smoking and drinking in relation to oral pharyngeal cancer. Cancer Res 48:3282–3287, 1988.
LaVecchia C, Negri E. The role of alcohol in esophageal cancer in non-smokers, and the role of tobacco in nondrinkers. Int J Cancer 43:784–785, 1989.
Micozzi MS. Foods, micronutrients, and reduction of human cancer. In Moon TE, Micozzi MS (eds): Nutrition and Cancer Prevention: Investigating the Role of Micronutrients. New York: Marcel Dekker, 1989, pp. 213–241.
Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta-carotene materially reduce cancer rates? Nature 290:201–208,1981.
Krinsky NI, Deneke SMAnteraction of oxygen and oxy-radicals with carotenoids. J Natl Cancer Inst 69:205–209, 1982.
Lippman SM, Meyskens FL Jr. Retinoids for the prevention of cancer. In Moon TE, Micozzi MS (eds): Nutrition and Cancer Prevention: Investigating the Role of Micronutrients. New York: Marcel Dekker, 1989, pp. 243–271.
Garewal HS. Potential role of beta-carotene in prevention of oral cancer. Am J Clin Nutr 53:294S–297S, 1991.
Mirvish SS. Blocking the formation ofN-nitroso compounds with fis orbicacidinvitroandinvivo. AnnN YAcad Sci 258:175–180, 1975.
Block G, Menkes M. Ascorbic acid in cancer prevention. In Moon TE, Micozzi MS (eds): Nutrition and Cancer Prevention: Investigating the Role of Micronutrients. New York: Marcel Dekker, 1989, pp. 341–388.
Block G. Vitamin C and cancer prevention: The epidemiologic evidence. Am J Clin Nutr 53:270S–282S, 1991.
Hirayama T. Life-Style and Mortality. Basel: Karger, 1990, pp. 73–95.
Bjelke E. Dietary vitamin A and human lung cancer. Int J Cancer 15:561–565, 1975.
Kvale G, Bjelke E, Gart JJ. Dietary habits and lung cancer risk. Int J Cancer 31:397–405, 1983.
Pisani P, Berrino F, Macaluso M, Pastorino U, Crosignani P, Baldasseroni A. Carrots, green vegetables and lung cancer: A case-control study. Int J Epidemiol 15:463–468, 1986.
Wald NJ, Boreham J, Bailey A. Serum retinol and subsequent risk of cancer. Br J Cancer 54:957–961, 1986.
Pastorino U, Pisani P, Berrino F, Andreoli C, Barbieri A, Costa A, Mazzoleni C, Gramegna G, Marubini E. Vitamin A and female lung cancer: A case-control study on plasma and diet. Nutr Cancer 10:171–179, 1987.
Ziegler RG, Morris LE, Blot WJ, Postern LM, Hoover R, Fraumeni JF Jr. Esophageal cancer among black men in Washington, D.C. II. Role of nutrition. J Natl Cancer Inst 67:1199–1206, 1981.
Tuyns AI, Riboli E, Doornbos G, Pequignot G. Diet and esophageal cancer in Calvados (France). Nutr Cancer 9:81–92, 1987.
Decarli A, Liati P, Negri E, Franceschi S, LaVecchia C. Vitamin A and other dietary factors in the etiology of esophageal cancer. Nutr Cancer 10:29–37, 1987.
Graham S, Marshall J, Haughey B, Brasure J, Freudenheim J, Zielezny M, Wilkinson G, Nolan J. Nutritional epidemiology of cancer of the esophagus. Am J Epidemiol 131:454–467, 1990.
McLaughlin JK, Gridley G, Block G; Winn DM, Preston-Martin S, Schoenberg JB, Greenberg RS, Stemhagen A, Austin DF, Ershow AG, Blot WJ, Fraumeni JF Jr. Dietary factors in oral and pharyngeal cancer. J Natl Cancer Inst 80:1237–1243, 1988.
Wattenberg LW. Chemoprevention of cancer. Cancer Res 45:1–8, 1985.
Boone CW, Kelloff GJ, Malone WE. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: A review. Cancer Res 50:2–9, 1990.
Meyskens FL. Coming of age—The chemoprevention of cancer. N Engl J Med 323:825–827, 1990.
Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LI, Dimery IW, Brown BW, Goepfert H. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 323:795–801, 1990.
Shimame LP, Menon MM, Bhide SV. Mutagenicity of betel quid and its ingredients using mammalian test systems. Carcinogenesis 5:501–503, 1984.
Stich HF, Rosin MP, Hornby AP, Mathew B, Sankaranarayanan R, Nair MK. Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A. Int J Cancer 42:195–199, 1988.
Stich HF, Mathew B, Sankaranarayanan R, Nair MK. Remission of precancerous lesions in the oral cavity of tobacco chewers and maintenanceof the protective effect of beta-carotene or vitamin A. Am J Clin Nutr 53:298S- 304S, 1991.
Lippman SM, Lee JS, Lotan R, Hittelman W, Wargovich MJ, Hong WK. Biomarkers as intermediate endpoints in chemoprevention trials. J Natl Cancer Inst 82:555–560, 1990.
Mulvihill JJ. Host factors in human lung tumors: An example of ecogenetics in oncology. J Nall Cancer Inst 57:37, 1976.
Spitz MR, Fueger JJ, Beddingficld NA, Annegers JF, Hsu TC, Newell GR, Schantz SP. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res 49:4626–4628, 1989.
Tyldesley WR. Oral leukoplakia associated with tylosis and esophageal carcinoma. J Oral Pathol 3:62–70, 1974.
O’Mahony MY, Ellis JP, Hellier M, Mann R, Huddy P. Familial tylosis and carcinoma of the oesophagus. J R Soc Med 77:514–517, 1984.
Iannuzzi MC, Miller YE. Genetic predisposition to lung cancer. Seminars in Respiratory Medicine 7.327–332, 1986.
Caporaso NE, Tucker MA, Hoover RN, Hayes RB, Pickle LW, Issaq HJ, Muschik GM, Green-Gallo L, Buivys D, Aisner S, Resau JH, Trump BF, Tollerud D, Ainsley W, Harris CC. Lung cancer and the debrisoquine metabolic phenotype. J Natl Cancer Inst 82:1264–1272, 1990.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Schottenfeld, D. (1992). The Etiology and Prevention of Aerodigestive Tract Cancers. In: Newell, G.R., Hong, W.K. (eds) The Biology and Prevention of Aerodigestive Tract Cancers. Advances in Experimental Medicine and Biology, vol 320. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3468-6_1
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3468-6_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6536-5
Online ISBN: 978-1-4615-3468-6
eBook Packages: Springer Book Archive